A Folate Receptor β-Targeted TLR7 Agonist Significantly Augments Checkpoint Inhibitor Potencies by Reprogramming Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells
Year: 2026
Type: article
Source: Journal of Medicinal Chemistry
Institution: Purdue University West Lafayette
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: Purdue University
OpenAlex ID: W7129538534
